A prospective cohort study to compare humoral immunity induced by a single dose of BNT162b2 in individuals with previous COVID-19 to that produced by two BNT162b2 doses
Latest Information Update: 21 Oct 2021
Price :
$35 *
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- 21 Oct 2021 New trial record
- 13 Oct 2021 Results published in the Vaccine